Live Price
Live Volume
Chart Volume 0
Volume 0
5 secNeuropace Market Segments
Regular Trading Hours
-0.93(-6.92%)
| Open | $13.44 |
|---|---|
| Close | $12.51 |
| Low | $12.40 |
| Low Change | -1.04 (-7.74%) |
| High | $13.44 |
| High Change | +0.00 (+0.00%) |
| Range | $1.04 |
| Volume | 49.94K |
| Dollar Volume | $624.75K |
Premarket
*No Trades in Segment
Overnight
*No Trades in Segment
After Hours Yesterday
-0.19(-1.42%)
| Open | $13.34 |
|---|---|
| Close | $13.15 |
| Low | $13.00 |
| Low Change | -0.34 (-2.55%) |
| High | $13.42 |
| High Change | +0.08 (+0.60%) |
| Range | $0.42 |
| Volume | 25.775K |
| Dollar Volume | $338.94K |
Regular Trading Hours Yesterday
+0.54(+4.22%)
| Open | $12.79 |
|---|---|
| Close | $13.33 |
| Low | $12.79 |
| Low Change | 0.00 (0.00%) |
| High | $13.94 |
| High Change | +1.15 (+8.99%) |
| Range | $1.15 |
| Volume | 180.124K |
| Dollar Volume | $2.40M |
Premarket Yesterday
*No Trades in Segment
Neuropace News
There is no current news for this stock at the moment.
Neuropace Top Trades
Neuropace's top trade so far today returned +0.89%, while the top short trade returned -7.74%.
Neuropace Moving Averages
| 5 Day Moving Average (SMA5) | $12.64 |
|---|---|
| 10 Day Moving Average (SMA10) | $12.82 |
| 20 Day Moving Average (SMA20) | $12.79 |
| 50 Day Moving Average (SMA50) | $13.60 |
| 100 Day Moving Average (SMA100) | $14.43 |
| 200 Day Moving Average (SMA200) | $14.91 |
Neuropace Statistics
| Average Volume (30 Days) | 130.68K |
|---|---|
| P/E Ratio (Current) | -22.62 |
| EPS (Current) | -$0.56 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$11.61M |
| Cash Ratio | 0.72 |
| Current Ratio | 4.94 |
| Quick Ratio | 3.91 |
| Debt to Equity | 4.97 |
| Enterprise Value | $481.36M |
| EV to EBITDA | -32.49 |
| EV to Sales | 4.87 |
| Price to Book | 36.60 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 4.40 |
| Return on Assets | -0.20% |
| Return on Equity | -1.61% |
Neuropace Stock Splits
There have been no stock splits for Neuropace (NPCE).
Neuropace Dividends
There have been no dividends for Neuropace (NPCE).